Research Topics
Genomes and GenesSpecies | Piercarlo Sarzi-PuttiniSummaryCountry: Italy Publications
| Collaborators
|
Detail Information
Publications
The characteristics of symptomatic osteoarthritis in general and specialist practice in Italy: design and methods of the AMICA StudyFabio Parazzini
Division of Epidemiology, Istituto Mario Negri, Milan, Italy
Semin Arthritis Rheum 35:11-6. 2005..The diagnostic and clinical approach to osteoarthritis (OA) of the hand, knee, and hip in general practice and specialist practice in Italy as determined by the AMICA project...
Dysfunctional syndromes and fibromyalgia: a 2012 critical digestPiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Clin Exp Rheumatol 30:143-51. 2012..This review will discuss the recent literature concerning the most common dysfunctional disorders: fibromyalgia syndrome, myalgic encephalomyelitis/chronic fatigue syndrome, and irritable bowel syndrome...
Multidisciplinary approach to fibromyalgia: what is the teaching?Piercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Ospedale L Sacco, Via GB Grassi 74, Milan, Italy
Best Pract Res Clin Rheumatol 25:311-9. 2011..Physical exercise and multimodal cognitive behavioural therapy are the most widely accepted and beneficial forms of non-pharmacological therapy...
Interleukin 6 blockade: tocilizumab in psoriatic arthritisFabiola Atzeni
Experimental Medicine, Queen Mary University of London, London, UK
J Rheumatol Suppl 89:97-9. 2012....
Chronic widespread pain: from peripheral to central evolutionPiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Best Pract Res Clin Rheumatol 25:133-9. 2011..The two models (neurochemical and biopsychosocial) also affect our ability to find therapeutic answers...
Central motor control failure in fibromyalgia: a surface electromyography studyRoberto Casale
Department of Clinical Neurophysiology and Pain Rehabilitation Unit, Salvatore Maugeri Foundation, IRCCS, Scientific Institute of Montescano, Montescano PV, Italy
BMC Musculoskelet Disord 10:78. 2009..The aim of this study was to assess whether the myoelectrical manifestations of fatigue in patients affected by FM are central or peripheral in origin...
B lymphocyte intestinal homing in inflammatory bowel diseaseCaterina Defendenti
Laboratory Unit, Fatebenefratelli Hospital, Milan, Italy
BMC Immunol 12:71. 2011..The objective is to investigate the localisation of immunoglobulin-producing cells (IPCs) in samples of inflamed intestinal tissue taken from patients with IBD, and their possible relationship with clinical features...
Cardiac involvement in systemic rheumatic diseases: An updatePiercarlo Sarzi-Puttini
L Sacco University Hospital, Milan, Italy
Autoimmun Rev 9:849-52. 2010..As these are all associated with an unfavourable prognosis, it is essential to detect subclinical cardiac involvement in asymptomatic SAD patients, and begin adequate management and treatment early...
Tumor necrosis factor-alpha, biologic agents and cardiovascular riskP Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Lupus 14:780-4. 2005..Due to the lack of evidence of a beneficial effect of anti-TNF-alpha agents in treatment of CHF, they should not be used to treat patients with New York Heart Association (NYHA) class III or IV heart failure...
Do physicians treat symptomatic osteoarthritis patients properly? Results of the AMICA experiencePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 35:38-42. 2005..The study was designed to evaluate their prescription modalities to determine whether they matched the recently proposed treatment guidelines for OA (ACR 2000; EULAR 2000; APS 2002)...
Osteoarthritis: an overview of the disease and its treatment strategiesPiercarlo Sarzi-Puttini
Division of Rheumatology, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 35:1-10. 2005..The disease course and patient's requirements often change over time, thus requiring a periodic review and readjustment of therapy rather than the rigid continuation of a single treatment...
Autoimmunity and anti-TNF-alpha agentsFabiola Atzeni
Rheumatology Unit, Department of Rheumatology, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
Ann N Y Acad Sci 1051:559-69. 2005..3% and in 12.9% of adalimumab-treated RA patients. Only limited data on the induction of aPL antibodies during TNF-alpha blocking treatment are available...
Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndromePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmunity 41:74-9. 2008..To investigate the prevalence of antipolymer antibody (APA) in patients with fibromyalgia (FM) and to examine its association with FM severity symptoms...
Fibromyalgia syndrome: the pharmacological treatment optionsP Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Reumatismo 60:50-8. 2008..The nature of FM suggests that an individualized, multimodal approach that includes both pharmacologic and nonpharmacologic therapies seems to be the most appropriate treatment strategy to date...
Osteoarthritis of the spinePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 34:38-43. 2005
Treatment strategy in fibromyalgia syndrome: where are we now?Piercarlo Sarzi-Puttini
Clinical Research Scientist, Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 37:353-65. 2008..The treatment of the fibromyalgia syndrome (FMS) is not standardized and often ineffective, and the course of disease progression is unpredictable...
Environment and systemic lupus erythematosus: an overviewPiercarlo Sarzi-Puttini
Rheumatology Unit, Department of Rheumatology, L Sacco University Hospital, Milan, Italy
Autoimmunity 38:465-72. 2005..A better understanding of the etiopathogenetic mechanism of SLE is required in order to clarify the multiple interactions between environmental exposures and genetic factors...
[Complementary medicine in rheumatoid arthritis]P Sarzi-Puttini
Unita di Reumatologia, Università Ospedale L Sacco, Via G B Grassi 74, 20157 Milano, Italia
Reumatismo 57:226-31. 2005....
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)P Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Reumatismo 60:290-5. 2008....
Increased neural sympathetic activation in fibromyalgia syndromePiercarlo Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milano, Italy
Ann N Y Acad Sci 1069:109-17. 2006..This review discusses the general aspects of the altered HPA and ANS, sympathetic overactivity, and alterations in cardiovascular autonomic responses to gravitational stimuli...
Pain and ketoprofen: what is its role in clinical practice?P Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Reumatismo 62:172-88. 2010....
New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis)Piercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
Curr Opin Rheumatol 16:287-92. 2004..Purpose of this review is to summarize new clinical, pathogenetic and therapeutic insights of this disease...
An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritisPiercarlo Sarzi-Puttini
Unità Operativa di Reumatologia, University Hospital L Sacco, Via G B Grassi 74, 20157 Milan, Italy
Rheumatol Int 25:15-22. 2005....
Cardiovascular involvement in psoriatic arthritisF Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan
Reumatismo 63:148-54. 2011..Active PsA is a risk factor for CVD, and so PsA patients should be screened for subclinical forms of the disease and its risk factors, and an early treatment approach should be adopted...
Infliximab-induced lupus in Crohn's disease: a case reportP Sarzi-Puttini
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Dig Liver Dis 35:814-7. 2003..This is the first case, to our knowledge, of onset of prolonged infliximab-induced lupus...
The Italian version of the Fibrofatigue Scale, a reliable tool for the evaluation of fibromyalgia symptomsP Sarzi-Puttini
Department of Rheumatology, University Hospital L Sacco, Via GB Grassi, 20157 Milan, Italy
J Psychosom Res 56:213-6. 2004..To validate a translated Italian version of the Fibrofatigue Scale (FFS)...
TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemmaPiercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Sacco, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 4:153-61. 2005....
Predicting response to anti-TNF treatment in rheumatoid arthritis patientsFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmun Rev 8:431-7. 2009..To identify the clinical factors predicting failure or a good clinical response in the cohort of RA patients entered in the Lombardy Rheumatology Network (LORHEN) registry after 3 years of treatment with anti-TNF agents...
Switching TNF-alpha antagonists in rheumatoid arthritis: the experience of the LORHEN registryRoberto Caporali
Division of Rheumatology, University of Pavia, IRCCS Policlinico S Matteo Foundation, Pavia, Italy
Autoimmun Rev 9:465-9. 2010..The patients with higher disease activity levels and those stopping the first anti-TNFalpha treatment because of a lack of efficacy are very likely to respond to the second treatment...
Unusual B cell morphology in inflammatory bowel diseaseCaterina Defendenti
Laboratory Unit, Fatebenefratelli Hospital, Milan, Italy
Pathol Res Pract 208:387-91. 2012....
Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patientsEnnio Giulio Favalli
UOC Day Hospital of Rheumatology, G Pini Orthopedic Institute, University of Milan, Milan, Italy
Autoimmun Rev 8:266-73. 2009..014), and the concomitant use of corticosteroids (p=0.029) as significant predictors of infections. There was no statistically significant difference in risk between the anti-TNFalpha agents...
TNF-alpha antagonist survival rate in a cohort of rheumatoid arthritis patients observed under conditions of standard clinical practiceAntonio Marchesoni
Day Hospital of Rheumatology, G Pini Orthopaedic Institute, Milan, Italy
Ann N Y Acad Sci 1173:837-46. 2009..Comorbidities, increasing DAS28 values and co-therapy with methotrexate were associated with a lower risk of discontinuation...
Long-term prognosis and causes of death in systemic lupus erythematosusAndrea Doria
Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Italy
Am J Med 119:700-6. 2006..We studied survival rate, prognostic factors, and causes of death in patients with systemic lupus erythematosus (SLE), particularly focusing on the influence of disease severity...
Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical valueFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmunity 41:111-5. 2008..The aim of this study was to assess thyroid function as well as the prevalence and clinical value of anti-thyroid antibodies in patients with rheumatoid arthritis (RA)...
CC chemokine receptor 5 polymorphism in Italian patients with Behcet's diseaseFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Rheumatology (Oxford) 51:2141-5. 2012..To evaluate the potential role of CC chemokine receptor 5 (CCR5)Δ32 polymorphism in the susceptibility to and clinical expression of Behçet's disease (BD) in a cohort of Italian patients...
Effect of adalimumab on neutrophil function in patients with rheumatoid arthritisFranco Capsoni
Department of Internal Medicine, Ospedale Maggiore Policlinico, IRCCS, University of Milan, Milan, Italy
Arthritis Res Ther 7:R250-5. 2005....
The heart in rheumatoid arthritisMaurizio Turiel
Cardiology Unit, Dipartimento di Tecnologie per la Salute, IRCCS Orthopedic Galeazzi Institute, University of Milan, Milan, Italy
Autoimmun Rev 9:414-8. 2010..As these are all associated with an unfavourable prognosis, it is essential to detect subclinical cardiac involvement in still asymptomatic RA patients in order to assure adequate long-term treatment...
Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgiaRaffaello Furlan
Department of Internal Medicine II, Ospedale L Sacco, Universita degli Studi di Milano, Milano, Italy
J Rheumatol 32:1787-93. 2005..We tested the hypothesis that FM is characterized by sympathetic overactivity and alterations in cardiovascular autonomic response to gravitational stimulus...
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: a reappraisalRoberto Caporali
Rheumatology Unit, University of Pavia, IRCCS Policlinico S Matteo Foundation, 27100 Pavia, Italy
Autoimmun Rev 8:274-80. 2009..As the first published registry of anti-TNFalpha-treated patients in Italy, Lombardy Rheumatology Network (LORHEN) is already making its contribution in this direction...
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective studyFabiola Atzeni
Rheumatology Unit, Department of Medicine, L Sacco University Hospital, 74 Via GB Grassi, 20157 Milano, Italy
Arthritis Res Ther 8:R3. 2006..Antinuclear and anti-dsDNA autoantibodies, but not anti-phospholipid autoantibodies, can be induced by adalimumab but to a lower extent than in studies with other anti-TNF blocking agents...
Organ-specific autoantibodies in patients with rheumatoid arthritis treated with adalimumab: a prospective long-term follow-upFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmunity 41:87-91. 2008..Aim of our study was to assess the prevalence and concentration of a panel of organ-specific autoantibodies in patients with RA and to evaluate their relationship with clinical manifestations and treatment efficacy...
Potential target of infliximab in autoimmune and inflammatory diseasesFabiola Atzeni
Rheumatology Unit, L Sacco Hospital, University of Milan, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 6:529-36. 2007..A number of other more rare disorders also may be responsive to TNF blockade. We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions...
Chronic widespread pain in the spectrum of rheumatological diseasesFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Best Pract Res Clin Rheumatol 25:165-71. 2011..A misdiagnosis harms the patients and the community. Rheumatologists should be able to recognise and distinguish primary and secondary FM, and need new guidelines and instruments to avoid making mistakes...
Long-term safety and efficacy of low-dose cyclosporin A in severe psoriatic arthritisPiercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Sacco, Milan, Italy
Rheumatol Int 21:234-8. 2002..The aim of this study was to evaluate the efficacy and tolerability of long-term treatment with cyclosporin A (CsA) in patients with psoriatic arthritis (PsA)...
What is the role of rituximab in the treatment of rheumatoid arthritis?Fabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 6:553-8. 2007....
Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseasesFabiola Atzeni
L Sacco University Hospital, Milan, Italy
Autoimmun Rev 9:845-8. 2010..Furthermore, plasma ADMA levels could be used as a simple means of screening SRD patients at higher CV risk who need more aggressive treatment aimed at slowing or reversing the progression of atherosclerosis...
Cardiovascular injury in systemic autoimmune diseases: an updateMaurizio Turiel
Department of Health Technologies, Cardiology Unit, IRCCS Orthopedic Galeazzi Institute, University of Milan, Via R Galeazzi 4, Milan, Italy
Intern Emerg Med 6:99-102. 2011..Moreover, chronic inflammation, accelerated atherosclerosis and functional abnormalities of the endothelium suggest a subclinical CV involvement beginning rapidly soon after the onset of the disease and progressing with disease duration...
Potential off-label use of infliximab in autoimmune and non-autoimmune diseases: a reviewFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, 20157 Milan, Italy
Autoimmun Rev 4:144-52. 2005..We here review the current and prospective roles of infliximab in the treatment of autoimmune diseases and other conditions that do not currently have FDA or EMEA approval...
Polymyositis-dermatomyositis and infectionsSandra Zampieri
University of Padova, Division of Rheumatology, Department of Clinical and Experimental Medicine, Italy
Autoimmunity 39:191-6. 2006..In this review, the increased risk of developing infections in these patients is also underlined and published data are reported...
Neuroendocrine therapy of fibromyalgia syndrome: an updatePiercarlo Sarzi-Puttini
Rheumatology Unit, University Hospital L Saccco, Milan, Italy
Ann N Y Acad Sci 1193:91-7. 2010..Studies predicting treatment response indicate that it is useful if not essential to tailor the choice of treatment components to the needs of individual patients...
Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitisFabiola Atzeni
Rheumatology Unit, L, Sacco Hospital, University of Milan, Via G, B, Grassi 74, 20127 Milan, Italy
Arthritis Res Ther 10:R51. 2008..The purpose of this study was to investigate the prevalence of cyclic citrullinated peptide antibodies (anti-CCP) in patients with primary Sjögren syndrome (pSS) and its correlation with clinical and laboratory data...
Cardiovascular involvement in systemic autoimmune diseasesSimona Sitia
IRCCS Orthopedic Galeazzi Institute, University of Milan, Department of Health Technologies, Cardiology Unit, Milan, Italy
Autoimmun Rev 8:281-6. 2009....
The role of echocardiographic techniques in connective tissue diseasesMaurizio Turiel
Department of Cardiology, Istituto Galeazzi, University of Milan, Via Galeazzi 4, 20161 Milano, Italy
Autoimmun Rev 4:171-7. 2005....
Estrogens in pregnancy and systemic lupus erythematosusAndrea Doria
Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Via Giustiniani, 2, 35128 Padova, Italy
Ann N Y Acad Sci 1069:247-56. 2006..This occurrence could lead to a lower-than-expected increase of IL-6, accounting for the low humoral immune response and the low disease activity observed in the third trimester of pregnancy in such patients...
Psoriatic arthritis: clinical improvement and correlation with hormone axes in etanercept-treated patientsFabiola Atzeni
Rheumatology Unit, University Hospital L Sacco, Milan, Italy
Ann N Y Acad Sci 1193:176-8. 2010..However, the greater increase in serum cortisol in comparison with serum 17OHP or ASD was related to clinical improvement, which indicates that the improvement was more related to the higher cortisol levels...
The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseasesFabiola Atzeni
L Sacco University Hospital, Milan, Italy
Autoimmun Rev 9:835-9. 2010..The effects on the CV system depend on the drug itself, the dose and the period of exposure, and so CV risk should be evaluated before starting treatment with any drug...
Anti-TNF therapy restores the hypothalamic-pituitary-adrenal axisFabiola Atzeni
Rheumatology Unit, University Hospital L Sacco, Milan, Italy
Ann N Y Acad Sci 1193:179-81. 2010..Long-term therapy with anti-TNF agents sensitizes the pituitary gland and improves adrenal androgen secretion, thus stimulating an alternative form of anti-inflammatory action...
Antigen preparation for immunological studies in systemic autoimmune diseasesSandra Zampieri
Division of Rheumatology, Department of Clinical and Experimental Medicine, University of Padova, Padova, Italy
Ann N Y Acad Sci 1109:193-202. 2007..In this review an overview of the different biochemical methods of antigen preparation and the specific methodological applications is given, also describing potential critical aspects and benefits of the different protocols...
Anti-cytokine antibodies for rheumatic diseasesFabiola Atzeni
L Sacco University Hospital, Rheumatology Unit, Via GB Grassi 74, 20127, Milan, Italy
Curr Opin Investig Drugs 10:1204-11. 2009..This review describes the efficacy and adverse events associated with anti-cytokine treatments for autoimmune rheumatic diseases...
Preclinical impairment of coronary flow reserve in patients with rheumatoid arthritisFabiola Atzeni
Rheumatology Unit, L Sacco Hospital, University of Milan, Milan, Italy
Ann N Y Acad Sci 1108:392-7. 2007..CFR is early reduced in RA patients without clinical evidence of heart disease as a result of impaired microcirculation. CFR seems a useful technique able to follow-up and to assess effects of new drugs on RA patients...
Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patientsMaurizio Turiel
Department of Health Technologies, Cardiology Unit, IRCCS Orthopedic Galeazzi Institute, University of Milan, Milano, Italy
Rheumatology (Oxford) 48:834-9. 2009....
Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective studyMaurizio Turiel
Department of Cardiology, Istituto Ortopedico Galeazzi, University of Milan, Via Galeazzi 4, 20161 Milan, Italy
Stroke 36:1490-4. 2005..Because thromboembolic events are frequently observed in primary antiphospholipid syndrome (PAPS), we assessed the risk factors for new thrombotic episodes...
Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional studyMaurizio Turiel
IRCCS Galeazzi Orthopedic Institute, University of Milan, Milan, Italy
Arthritis Care Res (Hoboken) 65:274-80. 2013..The aim of this pilot study was to use various endothelial and atherosclerosis markers to identify early cardiovascular involvement in a group of SSc patients...
Introduction: osteoarthritis in the third millennium: a new era for an old disease?Mario Carrabba
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Semin Arthritis Rheum 34:1-2. 2005
Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effectFausto Salaffi
Department of Rheumatology, Polytechnic University of the Marche Medical School, Via dei Colli 52, Jesi, Ancona, Italy
Arthritis Res Ther 11:R125. 2009....
Twelve years' experience with etanercept in the treatment of rheumatoid arthritis: how it has changed clinical practiceFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Expert Rev Clin Immunol 8:213-22. 2012..However, this is closely related to current RA activity and therefore suggests that it is not directly related to the drug. This article considers the published data in terms of clinical practice and changes in the progression of RA...
Primary and secondary autoimmune neutropeniaFranco Capsoni
Rheumatology Unit, Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy
Arthritis Res Ther 7:208-14. 2005..Granulocyte colony-stimulating factor is a proven treatment in patients with AIN of all types and is now preferred to other possible therapies...
Drug-induced lupus erythematosusPiercarlo Sarzi-Puttini
Department of Rheumatology, Rheumatology Unit, L Sacco University Hospital, Via GB Grassi 74, Milan 20157, Italy
Autoimmunity 38:507-18. 2005....
Systemic lupus erythematosus, atherosclerosis, and autoantibodiesSandra Zampieri
Division of Rheumatology, University of Padova, Via Giustiniani 2, I-35128 Padua, Italy
Ann N Y Acad Sci 1051:351-61. 2005....
Switching rheumatoid arthritis treatments: an updateFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Autoimmun Rev 10:397-403. 2011..However, many RA patients can be successfully treated with a second TNF antagonist, especially those discontinuing the first because of secondary failure or adverse events...
Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritisFabiola Atzeni
Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK
J Rheumatol 38:1661-4. 2011....
Detection of preclinical impairment of myocardial function in rheumatoid arthritis patients with short disease duration by speckle tracking echocardiographySimona Sitia
Cardiology Unit, Department of Health Technologies, IRCCS Galeazzi Orthopedic Institute, Universita di Milano, Milan, Italy
Int J Cardiol 160:8-14. 2012..The aim of this study was to assess whether STE can be useful to detect subclinical cardiac involvement in RA patients...
Hand osteoarthritisMario Fumagalli
Rehabilitative Medicine Unit, Istituti Clinici di Perfezionamento, Milan, Italy
Semin Arthritis Rheum 34:47-52. 2005
Resistant cases of psoriatic arthritis: how to manage themFabiola Atzeni
Rheumatology Unit, L Sacco Hospital, Milan, Italy
J Rheumatol Suppl 83:73-5. 2009..A number of clinical trials have shown that tumor necrosis factor antagonists are generally safe and efficacious in the treatment of PsA, and can inhibit the progression of radiographic damage...
2nd conference on heart, rheumatism and autoimmunity, Pescara, Italy, May 19-20, 2005Andrea Doria
Division of Rheumatology, University of Padova, Via Guistiniani 2, Padova 35128, Italy
Autoimmun Rev 5:55-63. 2006....
Combined therapeutic approach: inflammatory bowel diseases and peripheral or axial arthritisFabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milano, Italy
World J Gastroenterol 15:2469-71. 2009....
Validation of the reflux disease questionnaire for an Italian population of patients with gastroesophageal reflux diseaseFabio Pace
Department of Clinical Sciences, Division of Gastroenterology, L Sacco University Hospital, Milan, Italy
Eur J Gastroenterol Hepatol 20:187-90. 2008..As an English and a German version of the RDQ exist, but not an Italian one, we aimed at translating the RDQ into Italian and evaluating its reliability for the use of Italian-speaking GERD patients...
Cyclic alternating pattern: a new marker of sleep alteration in patients with fibromyalgia?Maurizio Rizzi
Center for Sleep and Respiratory Disorders, Rheumatology Unit, University Hospital L Sacco, Milan, Italy
J Rheumatol 31:1193-9. 2004..We evaluated the presence of CAP in patients with fibromyalgia (FM) compared to healthy controls...
Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I)P Sarzi-Puttini
Department of Rheumatology and Internal Medicine, University Hospital L Sacco, Milan, Italy
Clin Exp Rheumatol 21:459-64. 2003..To validate a translated Italian version of the Fibromyalgia Impact Questionnaire (FIQ)...
[Pharmacological treatment of fibromyalgia]M Cazzola
U O Reumatologia, Azienda Ospedaliera L Sacco, 20157 Milano, Italia
Reumatismo 59:280-91. 2007..The results of clinical trials of anti-inflammatory medications have been generally disappointing, but three RCTs have found that tramadol (with or without acetaminophen) is effective in FM...
Lamotrigine-induced lupusP Sarzi-Puttini
Rheumatology Unit, Department of Internal Medicine, University Hospital L Sacco, Milan, Italy
Lupus 9:555-7. 2000..To our knowledge, this is the first case report of an association between lamotrigine and the onset of SLE (systemic lupus erythematosus)...
Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health surveyF Salaffi
Department of Rheumatology, Polytechnic University of Marche, Ancona, Italy
Clin Exp Rheumatol 27:S67-74. 2009..To compare health-related quality of life (HRQL) in fibromyalgia (FM) patients with that of patients with rheumatoid arthritis (RA) and the general population, and investigate if the factors are associated with the greater impact of FM...
[Drug-induced lupus erythematosus]F Atzeni
Unità Operativa di Reumatologia, Università Ospedale L Sacco, Milano, Italia
Reumatismo 55:147-54. 2003..Recognition of DILE is important because it usually reverts within a few weeks after stopping the drug...
Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort studyF Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Aliment Pharmacol Ther 22:453-61. 2005..The potential clinical implications of autoimmunity during treatment with infliximab are unclear...
IgG anti-pentraxin 3 antibodies in systemic lupus erythematosusN Bassi
Division of Rheumatology, University of Padova, Via Giustiniani 2, Padua, Italy
Ann Rheum Dis 69:1704-10. 2010..To evaluate the prevalence and correlates of anti-pentraxin 3 (PTX3) antibodies in systemic lupus erythematosus (SLE)...
[Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome]P Sarzi-Puttini
Unità Operativa di Reumatologia, Azienda Ospedaliera, Polo Universitario L Sacco, Milan, Italy
Minerva Med 94:63-70. 2003..Primary and secondary APS are both associated with a significant increase of cardiovascular risk...
Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin AF Atzeni
Department of Rheumatology, L Sacco University Hospital, Milan, Italy
Clin Exp Rheumatol 21:759-62. 2003..The patient was successfully treated with cyclosporin A with no recurrence of the disease in the last 2 years...
Hypersomnolence in fibromyalgia syndromeP Sarzi-Puttini
Unità Operativa di Reumatologia, Azienda Ospedaliera, Polo Universitario L Sacco, Milan, Italy
Clin Exp Rheumatol 20:69-72. 2002..To evaluate hypersomnolence in patients affected by fibromyalgia syndrome...
Cardiac involvement in systemic lupus erythematosusA Doria
Division of Rheumatology, University of Padua, Padua, Italy
Lupus 14:683-6. 2005..Efforts should be made to control traditional risk factors as well as all other factors which could contribute to atherosclerotic plaque development...
[Early rheumatoid arthritis]F Atzeni
Unita di Reumatologia, Azienda Ospedaliera Polo Universitario L Sacco, Milano, Italia
Reumatismo 59:100-17. 2007..Because the tumor necrosis factor (TNF)-alpha inhibitors have proved to stop joint damage progression in severe progressive RA, the achievement of these agents in early RA are currently of great interest...
Diet therapy for rheumatoid arthritis. A controlled double-blind study of two different dietary regimensP Sarzi-Puttini
Department of Internal Medicine, University Hospital L Sacco, Milan, Italy
Scand J Rheumatol 29:302-7. 2000..To evaluate the effects of a diet therapy in patients with rheumatoid arthritis (RA)...
Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others)Fabiola Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Rheum Dis Clin North Am 32:413-26, viii. 2006..Serum matrix Gla protein may be a marker of osteometabolic syndromes that cause hyperostosis and plays a role in Milwaukee shoulder syndrome...
The role of NSAIDs in psoriatic arthritis: evidence from a controlled study with nimesulideP Sarzi-Puttini
University Hospital L Sacco, Rheumatology Unit, Department of Internal Medicine, Via G B Grassi 74, 20157 Milan, Italy
Clin Exp Rheumatol 19:S17-20. 2001..To define the optimal dose of nimesulide (NIM) for treating psoriatic arthritis...
Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled studyM Cazzola
Rheumatology Unit, Azienda Ospedaliera Polo Universitario L Sacco, Milan, Italy
Clin Exp Rheumatol 18:571-7. 2000..To evaluate the efficacy of oral chicken type II collagen (CII) in the treatment of rheumatoid arthritis (RA)...
A comparison of dothiepin versus placebo in the treatment of pain in rheumatoid arthritis and the association of pain with depressionP Sarzi Puttini
Rheumatology Service, L Sacco Hospital, Milan, Italy
J Int Med Res 16:331-7. 1988..Therapy with tricyclic anti-depressants, such as dothiepin, therefore, may determine an improvement of pain indexes besides having an anti-depressant effect...
The evaluation of the fibromyalgia patientsF Atzeni
Rheumatology Unit, L Sacco University Hospital, Milan, Italy
Reumatismo 60:36-49. 2008..To address the identification of core outcome domains, the Initiative on IMMPACT and OMERACT workshop convened a meeting to develop consensus recommendations for chronic pain clinical trials...
Etiopathogenetic mechanisms of fibromyalgia syndromeS Stisi
Rheumatology Unit, G Rummo Hospital, Benevento, Italy
Reumatismo 60:25-35. 2008..Understanding of pathogenetic pathways in FMS has advanced beyond observing patient responses to neurophysiologically targeted therapies and basic research...
Cardiac imaging techniques in systemic autoimmune diseasesM Turiel
Department of Cardiology, Istituto Ortopedico Galeazzi, University of Milan, Milan, Italy
Lupus 14:727-31. 2005..More recently, other imaging modalities including magnetic resonance and computerized tomography angiography have been developed to allow imaging of the coronary arteries...
HIV/AIDS: epidemic update, new treatment strategies and impact on autoimmunityF Croce
Department of Clinical Sciences L Sacco, University of Milan, Milan, Italy
Clin Exp Rheumatol 26:S48-52. 2008..Current epidemiological, therapeutic, autoimmune and rheumatic aspects of HIV-1 infection are here discussed...
OxLDL/beta2GPI-anti-oxLDL/beta2GPI complex and atherosclerosis in SLE patientsN Bassi
Division of Rheumatology, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
Autoimmun Rev 7:52-8. 2007..Many other studies are required to explain the role of autoantibodies in the pathogenesis of ATS in SLE patients, because the characteristics of SLE seem to mask their effects for atherogenesis...
Organ specific-autoantibodies: their role as markers and predictors of diseasePiercarlo Sarzi-Puttini
Autoimmunity 41:1-10. 2008
